Lemelson: Note Regarding Today’s Extraordinary Market Volatility

Lemelson Capital Management, LLC released the following note today to investors in The Amvona Fund, LP. regarding today’s extraordinary market volatility.

Note Regarding Today’s Extraordinary Market Volatility

Dear Partners,

The Dow fell 473 points today, about 1.79%, after plummeting as much as 648 points intra-day. The S&P 500 dropped 1.65%. Today marked the worst day for the Dow since January of this year. The Nasdaq sank 1.96%. All 30 of Dow components fell, and all 11 S&P sectors were lower in the broad sell-off.

Einhorn’s FOF Re-positions Portfolio, Makes New Seed Investment In Year Marked By “Speculative Exuberance”

david einhorn, reading, valuewalk, internet, investment research, Greenlight Capital, hedge funds, Greenlight Masters, famous hedge fund owners, big value investors, websites, books, reading financials, investment analysis, shortselling, investment conferences, shorting, short biasIt has not just been rough year for David Einhorn's own fund. Einhorn's Greenlight Masters fund of hedge funds was down 3% net for the first half of 2020, matching the S&P 500's return for those six months. In his August letter to investors, which was reviewed by ValueWalk, the Greenlight Masters team noted that Read More


Get Our Activist Investing Case Study!

Get the entire 10-part series on our in-depth study on activist investing in PDF. Save it to your desktop, read it on your tablet, or print it out to read anywhere! Sign up below!

Q1 hedge fund letters, conference, scoops etc

However, among the carnage was one particular stand-out, The Amvona Fund LP’s chief commitment, Geospace Technologies (NASDAQ: GEOS) which appreciated an extraordinary 3.77 percent (The Amvona Fund, LP as a whole was up significantly more than that today and management was actively buying stock in the market during the bloodbath).  While the road has hardly been smooth, Geospace stock has gained a remarkable 40.57 percent in the last twelve months, versus just 10.47 percent for the S&P 500 Total Returns Index. Despite the significant price appreciation, management continues to believe the stock remains dramatically undervalued. Notwithstanding the volatility, The Amvona Fund, LP is on track to have on of its best years since inception.

Ligand Pharmaceuticals (NASDAQ: LGND), a company management has openly declaimed against for years,1 actions that have resulted in an ongoing battle with US regulators, was not spared in the sell-off today, falling 2.62 percent (dropping as low as $119.50 intra-day). Since September 28, 2018, Ligand’s shares have fallen an incredible 56 percent, dramatically under-performing the benchmark S&P 500 index. Management believes Ligand’s stock has much further to fall.

Sincerely,

Rev. Fr. Emmanuel Lemelson - CIO

Lemelson Capital Management, LLC